|
業務類別
|
Biotechnology |
|
業務概覽
|
Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform. |
| 公司地址
| 5627 Oberlin Drive, Suite 120, San Diego, CA, USA, 92121 |
| 電話號碼
| +1 619 330-5499 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.iambic.ai |
| 員工數量
| 171 |
| Dr. Michael Secora, PhD |
Principal Accounting Officer, Chief Financial Officer and Chief Corporate Development Officer |
-- |
21/09/2026 |
| Dr. Neil Josephson, M.D. |
Chief Medical Officer |
-- |
21/09/2026 |
| Dr. Thomas Miller, PhD |
Chief Executive Officer and Director |
美元 572.46K |
21/09/2026 |
| Dr. Frederick Manby, PhD |
Chief Technology Officer and Director |
-- |
21/09/2026 |
| Dr. Peter Olson, PhD |
Chief Scientific Officer |
-- |
21/09/2026 |
|
|
| Dr. Mary A. Tagliaferri, M.D. |
Independent Director |
21/09/2026 |
| Ms. Shalini Sharp, M.B.A. |
Independent Director |
21/09/2026 |
| Dr. William H. Rastetter,PhD |
Independent Director |
21/09/2026 |
| Dr. Samit Hirawat, M.D. |
Independent Director |
21/09/2026 |
| Dr. Thomas Miller, PhD |
Chief Executive Officer and Director |
21/09/2026 |
| Dr. Frederick Manby, PhD |
Chief Technology Officer and Director |
21/09/2026 |
| Dr. Evan Rachlin, M.D. |
Independent Director |
21/09/2026 |
| Dr. R. Jacob Vogelstein, PhD |
Independent Director |
21/09/2026 |
| Mr. Kurt von Emster |
Independent Director |
21/09/2026 |
|
|
|
|